ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 6 analysts with an average price target of $23.79. This is a potential upside of $21.6 (986.3%) from yesterday's end of day stock price of $2.19.

Esperion Therapeutics's activity chart (see below) currently has 172 price targets and 164 ratings on display. The stock rating distribution of ESPR is 4.65% SELL, 81.4% BUY and 13.95% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.12% with an average time for these price targets to be met of 124.67 days.

Highest price target for ESPR is $16, Lowest price target is $2.5, average price target is $23.79.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 13-Dec-2024. First documented stock forecast 27-Oct-2014.

Currently out of the existing stock ratings of ESPR, 2 are a SELL (4.65%), 35 are a BUY (81.4%), 6 are a HOLD (13.95%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$13.81 (630.59%)

$16

8 days ago
(13-Dec-2024)

0/16 (0%)

$13.99 (696.02%)

Buy

$6

$3.81 (173.97%)

$6

8 days ago
(13-Dec-2024)

0/10 (0%)

$3.99 (198.51%)

Hold

$2.5

$0.31 (14.16%)

6 months 1 days ago
(20-Jun-2024)

2/4 (50%)

$0.21 (9.17%)

14

Hold

$9

1 years 1 months 1 days ago
(20-Nov-2023)

4/8 (50%)

$2.84 (46.10%)

92

Hold

$3

$0.81 (36.99%)

1 years 9 months 1 days ago
(20-Mar-2023)

4/7 (57.14%)

$1.46 (94.81%)

80

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 124.67 days on average for the stock forecasts to be realized with a an average price target met ratio 42.12

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

MARTIN AUSTER

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Martin Auster has 8 price targets and 3 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Alex Schwartz with highest potential upside - $102.81

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Jason Butler with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?